Which class of medications is commonly used to treat agoraphobia?

• A. Antipsychotics
• B. Beta-blockers
• C. SSRIs and SNRIs
• D. Benzodiazepines

Answer: (C)

Aggression toward everyday spaces is best addressed pharmacologically with SSRIs and SNRIs. These medications work by boosting brain serotonin—SSRs—and, in the SNRI class, also norepinephrine, which helps dampen the excessive fear and avoidance that define agoraphobia. They’ve shown solid efficacy in reducing panic frequency, generalized anxiety, and avoidance behaviors, making them suitable for long-term management of this condition. Because agoraphobia often lasts, choosing a treatment with a tolerable safety profile over the long haul is important, and SSRIs/SNRIs fit that need. It typically takes several weeks to feel noticeable improvement, so combining medication with exposure-based cognitive-behavioral therapy can enhance outcomes.

Benzodiazepines can rapidly ease anxiety, but they’re not ideal for sustained treatment due to dependence, tolerance, cognitive effects, and withdrawal risk, so they’re usually reserved for short-term or situational relief rather than first-line, ongoing management. Beta-blockers may help with physical symptoms like trembling or palpitations but don’t address the core anxiety and avoidance, so they aren’t a primary treatment for agoraphobia. Antipsychotics are not standard for this anxiety presentation unless another psychotic condition is present, given their side effects and limited evidence for agoraphobia.